Oaktree Capital racks up $2.3bn for inaugural life sciences lending fund

The fund will focus on sectors such as biopharma and medical devices.

23 June 2023•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.